Skip to main content
. 2020 Apr 18;7(2):271–285. doi: 10.1007/s40744-020-00206-7

Table 3.

Effects on serum glucose and/or insulin sensitivity exerted by systemic therapies for PsA

Drug class Effect on serum glucose or insulin sensitivity
Corticosteroids Worsen
Methotrexate Neutral
NSAIDs Neutral/improved
Leflunomide Neutral
Sulfasalazine Neutral
Anti-TNF-α Neutral/improved
Anti-IL-12/23 Neutral
Anti-IL-17A Neutral
Apremilast Neutral/improved